Abstract:Combined targeted drug delivery and sustained drug release, through the application of nanomedicine, show great potential in cancer therapy and diagnostics. Systems based on folic acid conjugated with graphene oxide-based magnetic nanoparticles (NPs) show distinct advantages for such chemotherapeutic applications. Herein, we prepared FA-Fe3O4@nGO-DOX magnetic nanoparticles (MNPs) with a uniform size distribution based on nanoscale graphene oxide (nGO) encapsulated Fe3O4, which was conjugated with folic acid (FA) and loaded with doxorubicin (DOX). The prepared MNPs were characterized by various biophysical methods and featured a uniform size distribution. The uniform size of the nGO resulted in a relative narrow size distribution of the Fe3O4@nGO MNPs, which contributed to the stability of the nanocarrier system. Cell viability and in vitro biocompatibility studies of the FA-Fe3O4@nGO-DOX NPs revealed their selective uptake by MGC-803 cells. The relative viability was maintained at ∼90% after 48 h of incubation, and the hemolysis ratio confirmed the low toxicity of our modified NPs. The pH-controlled drug release and selective uptake of FA-Fe3O4@nGO NPs by MGC-803 cells via the FA receptor ensured selective killing of tumor cells. Furthermore, the nanoparticles for magnetic resonance imaging were analyzed in vitro and their signal intensity decreased as the NP concentration was increased. The nanocomposite was highly effective for in vivo imaging. Additionally, our in vivo antitumor activity and histological analysis confirmed the selective anticancer activity of the FA-Fe3O4@nGO-DOX NPs. Notably, our NPs were highly active and mice treated with FA-Fe3O4@nGO-DOX showed lower weight loss compared with mice treated with Fe3O4@nGO-DOX. More necrotic tissue was observed in the tumors of the FA-Fe3O4@nGO-DOX group compared with those observed in the control, Fe3O4@nGO-DOX, and DOX groups. Thus, FA-Fe3O4@nGO-DOX is an effective and stable candidate for targeted drug delivery.

Alternating Magnetic Field Controlled Targeted Drug Delivery Based on Graphene Oxide-Grafted Nanosupramolecules

Multi-functionalized Graphene Oxide Based Anticancer Drug-Carrier with Dual-Targeting Function and Ph-Sensitivity

A Targeted Nano Drug Delivery System of AS1411 Functionalized Graphene Oxide Based Composites

Magnetically Controllable Polymer Nanotubes from a Cyclized Crosslinker for Site-Specific Delivery of Doxorubicin

Mitochondrion targeting peptide-modified magnetic graphene oxide delivering mitoxantrone for impairment of tumor mitochondrial functions

Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier.

Amphiphilic Prodrug-Decorated Graphene Oxide As a Multi-Functional Drug Delivery System for Efficient Cancer Therapy.

Graphene oxide-templated biomineralization nanosystem enables multi-drug loading and controllable release

Superparamagnetic Graphene Oxide–fe3o4 Nanoparticles Hybrid for Controlled Targeted Drug Carriers

Graphene Oxide-Based Magnetic Fluorescent Hybrids for Drug Delivery and Cellular Imaging.

Multi-transformable Nanocarrier with Tumor Extracellular Acidity-Activated Charge Reversal, Size Reduction and Ligand Reemergence for in Vitro Efficient Doxorubicin Loading and Delivery

Biocompatible and Stable GO-Coated Fe3O4 Nanocomposite: A Robust Drug Delivery Carrier for Simultaneous Tumor MR Imaging and Targeted Therapy

Functional Graphene Oxide As a Nanocarrier for Controlled Loading and Targeted Delivery of Mixed Anticancer Drugs.

A Smart Nanoassembly for Multistage Targeted Drug Delivery and Magnetic Resonance Imaging

Hyaluronic acid conjugated graphene oxide for targeted drug delivery

A Functionalized Graphene Oxide-Iron Oxide Nanocomposite for Magnetically Targeted Drug Delivery, Photothermal Therapy, and Magnetic Resonance Imaging

Hyaluronic acid and Arg-Gly-Asp peptide modified Graphene oxide with dual receptor-targeting function for cancer therapy

Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.

Fabrication and Antitumor Mechanism of a Nanoparticle Drug Delivery System: Graphene Oxide/Chitosan Oligosaccharide/γ‐Polyglutamic Acid Composites for Anticancer Drug Delivery

Sodium Alginate Conjugated Graphene Oxide As a New Carrier for Drug Delivery System

Multifunctionalization of graphene and graphene oxide for controlled release and targeted delivery of anticancer drugs